Cite
ESPAC-1: final results of a European, randomized controlled trial to assess the roles of adjuvant chemotherapy and adjuvant chemoradiation in resectable pancreatic cancer.
MLA
“ESPAC-1: Final Results of a European, Randomized Controlled Trial to Assess the Roles of Adjuvant Chemotherapy and Adjuvant Chemoradiation in Resectable Pancreatic Cancer.” British Journal of Surgery, vol. 91, no. 4, Apr. 2004, p. 520. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=13011935&authtype=sso&custid=ns315887.
APA
ESPAC-1: final results of a European, randomized controlled trial to assess the roles of adjuvant chemotherapy and adjuvant chemoradiation in resectable pancreatic cancer. (2004). British Journal of Surgery, 91(4), 520.
Chicago
“ESPAC-1: Final Results of a European, Randomized Controlled Trial to Assess the Roles of Adjuvant Chemotherapy and Adjuvant Chemoradiation in Resectable Pancreatic Cancer.” 2004. British Journal of Surgery 91 (4): 520. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=13011935&authtype=sso&custid=ns315887.